Taiwan’s National Science and Technology Council Visit


Leiden Bio Science Park (LBSP) welcomed a distinguished delegation from Taiwan’s National Science and Technology Council (NSTC) on April 17th, marking a dynamic morning of cross-border collaboration, knowledge exchange, and shared ambition in the field of healthcare innovation and data-driven science.

Hosted at the Plus Ultra building, the visit featured a lively lineup of presentations and discussions aimed at strengthening ties between Taiwanese research institutions and the growing biotech and medtech ecosystem of Leiden.

Esther Peters, Director of Leiden Bio Science Park, opened the session with a warm welcome presentation, setting the tone for the following talks.

A highlight of the event was the presentation by Dr. Kun-Hui Chen, Executive Director of Taiwan’s Smart Healthcare Committee and a leading orthopedic specialist. Dr. Chen shared insights into Taiwan’s applications of artificial intelligence in the medical industry, offering a glance into a future where diagnostics, patient care, and treatment personalization are all optimized through technology.

Three companies from the LBSP ecosystem- Leven Vision, Medis Medical Imaging, and Biotactical showcased their work in advanced therapies, AI, and early diagnostic tools. Presenting everything from smart imaging technologies to data-driven approaches in drug development, the speakers highlighted the rapid growth and innovation within the Dutch biotech and medtech ecosystem.

The Taiwanese delegation, included prominent academics, government leaders, and innovation advisors. Their curiosity, insightful questions, and collaborative spirit energized the session and reflected a strong mutual interest in building bridges between science communities.

This visit not only deepened mutual understanding but also laid the groundwork for future partnerships between Taiwan and the Netherlands in life sciences and health technology. As ideas continue to flow across borders, both regions stand to benefit from shared expertise, innovation, and a united vision for smarter, more connected healthcare.


  • Sharp rise in venture capital at Leiden Bio Science Park

    Companies at Leiden Bio Science Park attracted around €350 million in venture capital in 2025. That is significantly more than in previous years. This is according to research by real estate advisor CBRE. Venture capital is money invested in new…

  • Permit application submitted for production facility

    On 3 April 2026, RED Company submitted the permit application for the construction of Lilly’s production facility to the Municipality of Katwijk. To demonstrate that the development is feasible and complies with all applicable laws and regulations, RED Company has…

  • Large study reveals hidden potential of cancer drugs

    Patients with advanced cancer for whom standard treatments no longer work may benefit from off-label medicines: approved drugs that are used for a different disease than the one for which they are officially registered. This means a larger group of…